Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 May, 2018 09:01 IST
Glenmark Pharma gets USFDA nod for Fingolimod capsules
Source: IRIS | 20 Mar, 2017, 10.45AM
Comments  |  Post Comment

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Fingolimod Capsules, 0.5 Mg, the generic version of Gilenya Capsules of Novartis Pharmaceuticals Corp.

According to IMS Health sales data for the 12 month period ending January 2017, Gilenya Capsules, 0.5 mg achieved annual sales of approximately USD 2.03 billion.
 
Glenmark's current portfolio consists of 112 products authorized for distribution in the U.S. marketplace and approximately 65 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark (Q,N,C,F)* continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

All brand names and trademarks are the property of their respective owners.

Shares of the company declined Rs 11.4, or 1.29%, to trade at Rs 874.95. The total volume of shares traded was 12,617 at the BSE (10.38 a.m., Monday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Ashok Leyland quarterly net surges 40% - 18-May-2018 16:38
Bank of Baroda enters into MoU with CCRL - 18-May-2018 16:31
Strides Shasun turns to loss in Jan-Mar quarter - 18-May-2018 15:32
Bajaj Auto quarterly net up 36.33% - 18-May-2018 15:24
3i Infotech Services forays into retail as new vertical - 18-May-2018 13:04
Shriram Transport Finance inks MoU with HPCL - 18-May-2018 12:49
Airtel, Amazon India join hands to introduce a range of affordable 4G smartphones - 18-May-2018 12:11
L&T Construction wins orders worth Rs 15.04 bn - 18-May-2018 10:12
Glenmark Pharmaceuticals updates on clinical study of GBR 830 - 18-May-2018 10:08
R-Jio, Screenz partner to provide entertainment-based interactive platform - 18-May-2018 10:03
Sun Pharma launches generic Welchol tablets in US - 18-May-2018 09:49
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer